🔎 Trials Near Me

Akèy › Kansè pankreyas › Kalifòni › San Francisco

Etid klinik pou Kansè pankreyas nan San Francisco, CA

20 etid pou Kansè pankreyas ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Ap rekriteFaz 1/2
  • Research Site, San Francisco
Laj 18 a 130 · Tout sèks · Mizajou Oct 5, 2026 · NCT05417594

Distance-Based Exercise to Preserve Function and Prevent Disability

Ap rekrite
  • Kaiser Permanente-San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07059884

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Ap rekriteFaz 3
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07252232

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Ap rekriteFaz 3
  • Investigative Site US034, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07522073

UCSF PANC Cyst Registry

Ap rekriteEtid obsèvasyon
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT04291651

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Ap rekriteEtid obsèvasyon
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06271291

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Ap rekriteFaz 2
  • Local Institution - 0096, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07492680

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Ap rekriteEtid obsèvasyon
  • UCSF Medical Center-Mount Zion, San Francisco
  • UCSF Medical Center-Parnassus, San Francisco
  • UCSF Medical Center-Mission Bay, San Francisco
Laj 50 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT04239573

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Ap rekriteFaz 3
  • California Pacific Medical Center-Pacific Campus, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06958328

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Ap rekriteFaz 1
  • UCSF, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07066657

A Study of DM002 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • University of California San Francisco Cancer Center, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06751329

Pancreatic Cancer Early Detection Consortium

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of California, San Francisco (UCSF), San Francisco
Laj 18 a 90 · Tout sèks · Mizajou Jul 22, 2026 · NCT04970056

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Ap rekriteFaz 3
  • California Pacific Medical Center-Pacific Campus, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06998940

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Ap rekrite
  • Zuckerberg San Francisco General, San Francisco
  • Kaiser Foundation Research Institute, San Francisco
  • University of San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

A Study of MGC028 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • UCSF - Helen Diller Family Cancer Center, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Apr 27, 2026 · NCT06723236

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

Ap rekriteFaz 1 bonè
  • Stanford University, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Apr 3, 2026 · NCT07033689

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Ap rekriteFaz 1/2
  • University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT06244771

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Ap rekriteFaz 2
  • Ohio State University-Telemedicine, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT06906562

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Ap rekriteFaz 1/2
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT07145255

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, San Francisco
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè pankreyas nan lòt vil

Lòt etid nan San Francisco

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.